Altered Methylation of IGF2 DMR0 is Associated with Neural Tube Defects

Lihua Wu,Li Wang,Shaofang Shangguan,Shaoyan Chang,Zhen Wang,Xiaolin Lu,Qin Zhang,Jianhua Wang,Huizhi Zhao,Fang Wang,Jin Guo,Bo Niu,Jingzhu Guo,Ting Zhang

DOI: https://doi.org/10.1007/s11010-013-1655-1

IF: 3.842

2013-01-01

Molecular and Cellular Biochemistry

Abstract:Neural tube defects (NTDs) are serious congenital malformation of fusion failure of the neural tube during early embryogenesis. DNA methylation disorders have been found in NTD-affected fetuses, and are correlated to the risk of NTDs. The insulin-like growth factor 2 (IGF2) gene, maternally imprinted, has a key role in fetal development. IGF2 transcription is partly controlled by differentially methylated regions (DMRs) 0 and 2. To assess whether disturbed methylation pattern increases the incidence of NTDs, we employed matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) to quantify CpG methylation levels of DMR2 and 0 in fetuses with or without NTDs. We found that the methylation level of IGF2 DMR0 increased significantly in the brain tissues of NTD-affected fetuses. And hypermethylation of DMR0 was associated with an increased risk of NTDs, with an odds ratio of 5.375 (95 % CI: 1.447-19.965; p = 0.007). IGF2 mRNA expression was negatively correlated with the methylation level of DMR0 (R (2) = 0.893; p = 0.000) in HCT15 cells. These results highlights that IGF2 DMR0 hypermethylation is a potential risk factor of NTD, and IGF2 gene is a promising candidate gene to study for a greater understanding of the cause of NTDs.